Live

Novo Nordisk A/S Common Stock (NVO) congressional disclosures

Sector not mapped · coverage Sep 2, 2024–Sep 25, 2026

Email me the next NVO filing — free
Tracked disclosures
24
Lawmakers
9
Reported purchase / sale rows
16 / 8A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Sale

Kevin Hern

NVONovo Nordisk A/S Common Stock

$1K - $15K

Traded
Sep 10, 2026
Filed
Sep 25, 2026
Disclosure delay
15 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Nov 16, 2026.

Official filing

NVO congressional trades snapshot

This page summarizes public STOCK Act disclosures involving NVO. It is useful for seeing which lawmakers reported NVO transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Sep 25, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the NVO congressional trade page shows

Congressional Trader tracks 24 public STOCK Act disclosures for NVOacross 9 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent NVO filing shown here was filed on Sep 25, 2026 by Kevin Hern as a sale. Related lawmakers include Scott Franklin, Lisa C. McClain, Marjorie Taylor Greene, Byron Donalds, John James.

FAQ

Which lawmakers traded NVO?

Recent NVO disclosures include Scott Franklin, Lisa C. McClain, Marjorie Taylor Greene, Byron Donalds, John James.

What is the buy/sell mix for NVO?

The visible sample currently shows 16 purchases and 8 sales or partial sales.

Should I trade based on NVO disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.